UBE2C and esophageal squamous cell carcinoma: Interestingly, through subgroup analysis of ESCC patients at different stages, we found that in early stage of ESCC patients (stage II), patients with high expression of UBE2C tended to have higher OS, and p value was not statistically significant (Fig. 6b).